Healthcare
Live Price
Offline$17.53
+3.36% today
1Y Change
-19.93%
Window
Jun 23, 2025 → Jun 10, 2026
Coverage: 243 bars · Jun 23, 2025 → Jun 10, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sarepta Therapeutics, Inc. (SRPT) is a Healthcare stock with a market cap of $2.26B and listed on NASDAQ. The stock last traded around $17.53 and down 19.9% across the available one-year price window (Jun 23, 2025 → Jun 10, 2026). Baseline metrics include revenue growth of +15.6%, EPS growth of -388.7%, a dividend yield of 0.0%. What stands out right now is revenue +15.6%, EPS -388.7%, free cash flow +12.8% with operating margin -31.8% and ROIC -30.9%. Valuation is more restrained than many high-expectation growth names at price/sales 1.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SRPT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SRPT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SRPT Max Drawdown
-45.70%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SRPT and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.